Maxim Group Initiates Coverage On Alimera Sciences with Buy Rating, Announces Price Target of $10
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Naz Rahman initiates coverage on Alimera Sciences (NASDAQ:ALIM) with a Buy rating and a price target of $10.
March 25, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Maxim Group analyst Naz Rahman has initiated coverage on Alimera Sciences with a Buy rating and set a price target of $10.
The initiation of coverage by a reputable analyst with a Buy rating and a significant price target suggests a positive outlook for Alimera Sciences. This endorsement could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100